MYND Life Sciences Inc. (CSE:MYND)

Canada · Delayed Price · Currency is CAD

0.0700

0.00 (0.00%)

Apr 22, 2025, 5:08 PM EST

MYND Life Sciences Financials Overview

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul '24 Jul 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019
Gross Profit	-0.33	-0.33	-0.23	-	-	-
Operating Income	-1.29	-1.83	-3.06	-4.29	-0.06	-0
Net Income	-0.54	-1.52	-3.57	-4.37	-0.06	-0
Earnings Per Share	-0.01	-0.03	-0.08	-0.10	-0.00	-0.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul '24 Jul 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019
Cash & Investments	0	0	0	1.9	-	-
Total Debt	3	3	2.59	2.32	-	-
Net Cash (Debt)	-3	-3	-2.59	-0.42	-	-
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.06	-0.06	-0.06	-0.01	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul '24 Jul 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019
Operating Cash Flow	-0.17	-0.2	-1.82	-2.98	-0	-0
Capital Expenditures	-	-	-	-0.04	-	-
Free Cash Flow	-0.17	-0.2	-1.82	-3.03	-0	-0
Free Cash Flow Growth	-	-	-	-	-	-